| Dr Arshad M Sheikh, MD | |
|
7610 Carroll Ave, Suite 220, Takoma Park, MD 20912-6384 | |
| (301) 891-6060 | |
| (301) 891-6171 |
| Full Name | Dr Arshad M Sheikh |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 50 Years |
| Location | 7610 Carroll Ave, Takoma Park, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467445791 | NPI | - | NPPES |
| 257611200 | Medicaid | MD | |
| 00319D23 | Other | DC | MEDICARE PTN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D20255 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Healthcare White Oak Medical Center | Silver spring, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adventist Physician Services Inc | 4284631540 | 123 |
News Archive
A biochemical pathway that helps keep cells alive when oxygen is low also plays a role in longevity and resistance against some diseases of old age, according to a report to be published April 16 in the journal Science.
GenSpera, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to begin a Phase I study with its target activated pro-drug, G-202, for the treatment of cancer.
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding.
Researchers have identified a gene that directly affects the production of a form of hemoglobin that is instrumental in modifying the severity of the inherited blood disorders sickle cell disease and thalassemia.
DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, has been recognized by the Denver Business Journal as Metro Denver's healthiest extra-large employer. This is the fourth consecutive year the company has topped the list because of its commitment to teammate health and wellness.
› Verified 4 days ago
| Entity Name | Medical Faculty Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
A biochemical pathway that helps keep cells alive when oxygen is low also plays a role in longevity and resistance against some diseases of old age, according to a report to be published April 16 in the journal Science.
GenSpera, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to begin a Phase I study with its target activated pro-drug, G-202, for the treatment of cancer.
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding.
Researchers have identified a gene that directly affects the production of a form of hemoglobin that is instrumental in modifying the severity of the inherited blood disorders sickle cell disease and thalassemia.
DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, has been recognized by the Denver Business Journal as Metro Denver's healthiest extra-large employer. This is the fourth consecutive year the company has topped the list because of its commitment to teammate health and wellness.
› Verified 4 days ago
| Entity Name | Community Clinic, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790730281 PECOS PAC ID: 6204722614 Enrollment ID: O20040224000222 |
News Archive
A biochemical pathway that helps keep cells alive when oxygen is low also plays a role in longevity and resistance against some diseases of old age, according to a report to be published April 16 in the journal Science.
GenSpera, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to begin a Phase I study with its target activated pro-drug, G-202, for the treatment of cancer.
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding.
Researchers have identified a gene that directly affects the production of a form of hemoglobin that is instrumental in modifying the severity of the inherited blood disorders sickle cell disease and thalassemia.
DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, has been recognized by the Denver Business Journal as Metro Denver's healthiest extra-large employer. This is the fourth consecutive year the company has topped the list because of its commitment to teammate health and wellness.
› Verified 4 days ago
| Entity Name | Adventist Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376623207 PECOS PAC ID: 4284631540 Enrollment ID: O20061030000122 |
News Archive
A biochemical pathway that helps keep cells alive when oxygen is low also plays a role in longevity and resistance against some diseases of old age, according to a report to be published April 16 in the journal Science.
GenSpera, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to begin a Phase I study with its target activated pro-drug, G-202, for the treatment of cancer.
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding.
Researchers have identified a gene that directly affects the production of a form of hemoglobin that is instrumental in modifying the severity of the inherited blood disorders sickle cell disease and thalassemia.
DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, has been recognized by the Denver Business Journal as Metro Denver's healthiest extra-large employer. This is the fourth consecutive year the company has topped the list because of its commitment to teammate health and wellness.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arshad M Sheikh, MD 7610 Carroll Ave, Suite 220, Takoma Park, MD 20912-6384 Ph: (301) 891-6060 | Dr Arshad M Sheikh, MD 7610 Carroll Ave, Suite 220, Takoma Park, MD 20912-6384 Ph: (301) 891-6060 |
News Archive
A biochemical pathway that helps keep cells alive when oxygen is low also plays a role in longevity and resistance against some diseases of old age, according to a report to be published April 16 in the journal Science.
GenSpera, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to begin a Phase I study with its target activated pro-drug, G-202, for the treatment of cancer.
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding.
Researchers have identified a gene that directly affects the production of a form of hemoglobin that is instrumental in modifying the severity of the inherited blood disorders sickle cell disease and thalassemia.
DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, has been recognized by the Denver Business Journal as Metro Denver's healthiest extra-large employer. This is the fourth consecutive year the company has topped the list because of its commitment to teammate health and wellness.
› Verified 4 days ago
Dr. Pablo V Renart, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7610 Carroll Ave, Suite 210, Takoma Park, MD 20912 Phone: 301-270-2379 Fax: 301-270-2349 | |
Dr. Lisa Michaela Godette, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7610 Carroll Ave, Suite #450, Takoma Park, MD 20912 Phone: 301-270-2144 Fax: 301-270-2141 | |
Dr. Prathap R Naini, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7620 Carroll Ave Ste 201, Takoma Park, MD 20912 Phone: 301-891-6647 Fax: 301-891-6654 | |
Dr. Mitra Foroogh-nassiraee, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7620 Carroll Ave Ste 201, Takoma Park, MD 20912 Phone: 018-916-6473 Fax: 301-891-6654 |